CHC Healthcare Group (TPE:4164)

Market Cap	8.94B
Revenue (ttm)	4.07B
Net Income (ttm)	187.06M
Shares Out	185.71M
EPS (ttm)	1.01
PE Ratio	47.51
Forward PE	19.11
Dividend	1.51 (3.17%)
Ex-Dividend Date	Jun 26, 2025

Volume	610,011
Average Volume	1,561,266
Open	47.45
Previous Close	47.65
Day's Range	47.45 - 48.20
52-Week Range	35.50 - 60.40
Beta	0.36
RSI	49.72
Earnings Date	Nov 7, 2025

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.